Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?

Intravenous Immunoglobulin G (IVIG) therapy has been used as a component of the treatment of hemolytic disease of the newborn. There is still no consensus on its use in ABO hemolytic disease of the newborn routinely. The aim of this study is to determine whether administration of IVIG to newborns wi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Beken, Serdar, Hirfanoglu, Ibrahim, Turkyilmaz, Canan, Altuntas, Nilgun, Unal, Sezin, Turan, Ozden, Onal, Esra, Ergenekon, Ebru, Koc, Esin, Atalay, Yildiz
Format: Artigo
Jezik:Inglês
Izdano: Springer India 2012
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921323/
https://ncbi.nlm.nih.gov/pubmed/24554813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-012-0186-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items